Factor XIII Val34Leu polymorphism in patients with Cardiac Syndrome X

Abstract

(23.5% vs. 11.1%, p = 0.04). Factor XIII (Val/ /Leu + Leu/Leu) mutation (p = 0.01, OR = 3.42; OR = 3.33, were identified as independent predictors of the disease in multivariate regression analysis. Val34Leu polymorphism and CSX. (Cardiol J 2014; 21, 1: 6-10) Conclusions: This study indicates that there is an evidence for association between factor XIII

Thrombophilic Gene Mutations in Relation to Different Manifestations of Venous Thromboembolism: A Single Tertiary Center Study

“…Laboratory screening and Hcy measurements were performed according to the methods previously reported (Table 1). 8,9…”

“…Laboratory screening and Hcy measurements were performed according to the methods previously reported (Table 1). 8,9 Statistical Analysis Data were processed using the SPSS version 16.0 package (Statistical Package for Social Sciences Inc, Chicago, Illinois) and were expressed as number, mean, standard deviation, minimum and maximum for continuous variables, and number and percent for categorical variables, respectively. When continuous variables did not show a normal distribution, the Mann-Whitney U test was used.…”